4.5 Review

Infectious diseases in humanized mice

期刊

EUROPEAN JOURNAL OF IMMUNOLOGY
卷 43, 期 9, 页码 2246-2254

出版社

WILEY
DOI: 10.1002/eji.201343815

关键词

Dengue virus; EBV; HIV; Mycobacterium tuberculosis; Salmonella enterica typhi

资金

  1. National Cancer Institute [R01CA108609]
  2. Sassella Foundation [10/02, 11/02, 12/02]
  3. Cancer Research Switzerland [KFS-02652-08-2010]
  4. Association for International Cancer Research [11-0516]
  5. KFSPMS of the University of Zurich
  6. KFSPHLD of the University of Zurich
  7. Vontobel Foundation
  8. Baugarten Foundation
  9. EMDO Foundation
  10. Sobek Foundation
  11. Fondation Acteria
  12. Novartis
  13. Swiss National Science Foundation [310030_143979, CRSII3_136241]
  14. Worldwide Cancer Research [11-0516] Funding Source: researchfish

向作者/读者索取更多资源

Despite many theoretical incompatibilities between mouse and human cells, mice with reconstituted human immune system components contain nearly all human leukocyte populations. Accordingly, several human-tropic pathogens have been investigated in these in vivo models of the human immune system, including viruses such as human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV), as well as bacteria such as Mycobacterium tuberculosis and Salmonella enterica Typhi. While these studies initially aimed to establish similarities in the pathogenesis of infections between these models and the pathobiology in patients, recent investigations have provided new and interesting functional insights into the protective value of certain immune compartments and altered pathology upon mutant pathogen infections. As more tools and methodologies are developed to make these models more versatile to study human immune responses in vivo, such improvements build toward small animal models with human immune components, which could predict immune responses to therapies and vaccination in human patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据